Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen

被引:7
作者
Yan, Zhong-Hua [1 ]
Burkhardt, Anne [1 ]
Loke, Huay-Keng [1 ]
Chen, Jesse [1 ]
Xu, Qing [1 ]
Brauer, Pam [1 ]
Ma, Jingya [1 ]
Lin, Yafang [1 ]
Garcia, Khris [1 ]
Dick, Lawrence R. [1 ]
Bembenek, Michael E. [1 ]
机构
[1] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
MLN4924; AlphaScreen; Cell-based assay; Pathway inhibition; CANCER; ACTIVATION;
D O I
10.1016/j.ab.2013.04.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cellular effects of a Nedd8-activating enzyme (NAE) inhibitor, MLN4924, using the AlphaScreen format were explored. MLN4924 acts as a substrate-assisted inhibitor of NAE by forming a tight binding Nedd8-MLN4924 adduct. The inhibited enzyme can no longer transfer Nedd8 downstream to modify and activate the E3 cullin-RING ligases. This results in the stabilization of proteins regulated by the proteasome, leading to cell death. These studies monitored the endogenous cellular changes to NAE similar to Nedd8 thioester, the formation of the Nedd8-MLN4924 adduct, and the reduction in the Cul1-Nedd8. Lysates derived from MLN4924-treated HCT116 cells showed that whereas the beta-subunit of NAE remained constant, reductions of both NAE similar to Nedd8 thioester and Cul1-Nedd8 levels occurred with a concomitant rise of the adduct. Moreover, the formation of the Nedd8-MLN4924 adduct was approximately stoichiometric with the concentration of NAE beta. Higher density 384-well cell-based assays illustrated the kinetics of enzyme inactivation across a wider range of MLN4924 concentrations, showing a rapid loss of NAE similar to Nedd8 thioester and Cul1-Nedd8. The reduction of NAE similar to Nedd8 thioester precedes the loss of Cul1-Nedd8 at twice the rate. Finally, these results clearly demonstrate the utility of the homogeneous assay for quantitative assessment of these endogenous cellular components in a 384-well plate in response to inhibition of NAE by MLN4924. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 36 条
  • [21] An alternative and efficient synthesis of MLN4924, a selective NEDD8 inhibitor
    Kim, Hong-Rae
    Hyun, Young Eum
    Jarhad, Dnyandev B.
    Yu, Jinha
    Jeong, Lak Shin
    ORGANIC CHEMISTRY FRONTIERS, 2019, 6 (14) : 2480 - 2487
  • [22] MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study
    Lin, Wei-Chou
    Kuo, Kuan-Lin
    Shi, Chung-Sheng
    Wu, June-Tai
    Hsieh, Ju-Ton
    Chang, Hong-Chiang
    Liao, Shih-Ming
    Chou, Chien-Tso
    Chiang, Chih-Kang
    Chiu, Wei-Shuo
    Chiu, Tzu-Yuan
    Pu, Yeong-Shiau
    Ho, I-Lin
    Wang, Zuo-He
    Chang, Shih-Chen
    Liu, Shing-Hwa
    Jeng, Yung-Ming
    Huang, Kuo-How
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (11): : 3350 - 3362
  • [23] Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma
    McMillin, Douglas W.
    Jacobs, Hannah M.
    Delmore, Jake E.
    Buon, Leutz
    Hunter, Zachary R.
    Monrose, Val
    Yu, Jie
    Smith, Peter G.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Treon, Steven P.
    Kung, Andrew L.
    Mitsiades, Constantine S.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) : 942 - 951
  • [24] The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity
    Malhab, Lara J. Bou
    Descamps, Simon
    Delaval, Benedicte
    Xirodimas, Dimitris P.
    SCIENTIFIC REPORTS, 2016, 6
  • [25] Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
    Brownell, James E.
    Sintchak, Michael D.
    Gavin, James M.
    Liao, Hua
    Bruzzese, Frank J.
    Bump, Nancy J.
    Soucy, Teresa A.
    Milhollen, Michael A.
    Yang, Xiaofeng
    Burkhardt, Anne L.
    Ma, Jingya
    Loke, Huay-Keng
    Lingaraj, Trupti
    Wu, Dongyun
    Hamman, Kristin B.
    Spelman, James J.
    Cullis, Courtney A.
    Langston, Steven P.
    Vyskocil, Stepan
    Sells, Todd B.
    Mallender, William D.
    Visiers, Irache
    Li, Ping
    Claiborne, Christopher F.
    Rolfe, Mark
    Bolen, Joseph B.
    Dick, Lawrence R.
    MOLECULAR CELL, 2010, 37 (01) : 102 - 111
  • [26] Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
    Swords, Ronan T.
    Kelly, Kevin R.
    Smith, Peter G.
    Garnsey, James J.
    Mahalingam, Devalingam
    Medina, Ernest
    Oberheu, Kelli
    Padmanabhan, Swaminathan
    O'Dwyer, Michael
    Nawrocki, Steffan T.
    Giles, Francis J.
    Carew, Jennifer S.
    BLOOD, 2010, 115 (18) : 3796 - 3800
  • [27] Structure-based identification of a NEDD8-activating enzyme inhibitor via drug repurposing
    Wu, Ke-Jia
    Zhong, Hai-Jing
    Li, Guodong
    Liu, Chenfu
    Wang, Hui-Min David
    Ma, Dik-Lung
    Leung, Chung-Hang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1021 - 1027
  • [28] Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis
    Cooper, Jonathan
    Xu, Qingwen
    Zhou, Lu
    Pavlovic, Milica
    Ojeda, Virginia
    Moulick, Kamalika
    de Stanchina, Elisa
    Poirier, John T.
    Zauderer, Marjorie
    Rudin, Charles M.
    Karajannis, Matthias A.
    Hanemann, C. Oliver
    Giancotti, Filippo G.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1693 - 1704
  • [29] Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice
    Pai, Chien-Chun Steven
    Khuat, Lam T.
    Chen, Mingyi
    Murphy, William J.
    Abedi, Mehrdad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) : 30 - 37
  • [30] SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy
    Zhou, Li-Na
    Xiong, Chaodong
    Cheng, Yong-Jun
    Song, Shan-Shan
    Bao, Xu-Bin
    Huan, Xia-Juan
    Wang, Tong-Yan
    Zhang, Ao
    Miao, Ze-Hong
    He, Jin-Xue
    NEOPLASIA, 2022, 32